Feb 27 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O:
CYCLACEL PHARMACEUTICALS ANNOUNCES CLOSING OF A CHANGE OF CONTROL TRANSACTION AND APPOINTMENT OF NEW EXECUTIVE LEADERSHIP
CYCLACEL PHARMACEUTICALS INC - DAVID LAZAR RESIGNS AS INTERIM CEO AND SECRETARY
CYCLACEL PHARMACEUTICALS INC - DATUK DR. DORIS WONG SING EE ELECTED AS CEO AND EXECUTIVE DIRECTOR
CYCLACEL PHARMACEUTICALS INC - KIU CU SENG APPOINTED AS EXECUTIVE DIRECTOR, SECRETARY AND CFO
Source text: ID:nGNX2q1q8
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.